Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

<jats:sec><jats:title>Objectives</jats:title><jats:p>To use a data-driven approach to determine the existence and natural history of subtypes of Parkinson’s disease (PD) using two large independent cohorts of patients newly diagnosed with this condition.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>1601 and 944 patients with idiopathic PD, from Tracking Parkinson’s and Discovery cohorts, respectively, were evaluated in motor, cognitive and non-motor domains at the baseline assessment. Patients were recently diagnosed at entry (within 3.5 years of diagnosis) and were followed up every 18 months. We used a factor analysis followed by a k-means cluster analysis, while prognosis was measured using random slope and intercept models.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>We identified four clusters: (1) <jats:italic></jats:italic><jats:italic>fast motor progression</jats:italic> with symmetrical motor disease, poor olfaction, cognition and postural hypotension; (2) <jats:italic>mild motor and non-motor disease</jats:italic> with intermediate motor progression; (3) <jats:italic>severe motor disease</jats:italic>, <jats:italic>poor psychological well-being</jats:italic> and <jats:italic></jats:italic><jats:italic>poor sleep</jats:italic> with an intermediate motor progression; (4) <jats:italic>slow motor progression</jats:italic> with tremor-dominant, unilateral disease. Clusters were moderately to substantially stable across the two cohorts (kappa 0.58). Cluster 1 had the fastest motor progression in Tracking Parkinson’s at 3.2 (95% CI 2.8 to 3.6) UPDRS III points per year while cluster 4 had the slowest at 0.6 (0.1–1.1). In Tracking Parkinson’s, cluster 2 had the largest response to levodopa 36.3% and cluster 4 the lowest 28.8%.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>We have found four novel clusters that replicated well across two independent early PD cohorts and were associated with levodopa response and motor progression rates. This has potential implications for better understanding disease pathophysiology and the relevance of patient stratification in future clinical trials.</jats:p></jats:sec>

Original publication

DOI

10.1136/jnnp-2018-318337

Type

Journal article

Journal

Journal of Neurology, Neurosurgery & Psychiatry

Publisher

BMJ

Publication Date

12/2018

Volume

89

Pages

1279 - 1287